{"title":"美国成年人睡眠质量与生命基本心血管健康评分和代谢综合征的关系","authors":"Zhi Lin, Nipith Charoenngam, Izzuddin M Aris","doi":"10.1089/met.2025.0033","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Recent studies have identified a U-shaped association between sleep duration and both poor cardiovascular health (CVH) and metabolic syndrome (MetS). However, the extent to which sleep quality affects cardiometabolic health remains understudied. Here, we examined associations of sleep quality with CVH and MetS. <b><i>Methods:</i></b> In a nationally representative cross-sectional study of US adults (<i>n</i> = 3,293), we assessed sleep quality using the Pittsburgh Sleep Quality Index (PSQI), operationalized as a continuous score (range 0-23 points) and binary (good vs. poor sleep quality) variable. We derived CVH score (range 0-100 points) using the Life's Essential 8 construct, and defined MetS using the National Cholesterol Education Program Adult Treatment Panel III criteria. We examined associations via regression models, adjusting for sociodemographic and lifestyle factors. <b><i>Results:</i></b> In fully adjusted models, a 1-point higher PSQI score was associated with lower CVH scores (β -0.61; 95% CI -0.72, -0.51) and higher odds of MetS (OR 1.02; 95% CI 1.00, 1.03). Similarly, poor (vs. good) quality sleep was associated with lower CVH scores (β -4.1; 95% CI -5.4, -2.8) and higher odds of MetS (OR 1.27; 95% CI 1.04, 1.56). The associations with CVH score and MetS appeared to be driven primarily by health behaviors metrics and hypertriglyceridemia, respectively. No significant interactions were seen with age or gender. <b><i>Conclusions:</i></b> In this cross-sectional study, individuals with poor sleep quality were found to have worse CVH scores and higher odds of MetS. Future studies could explore whether strategies promoting better quality sleep would help improve CVH and prevent MetS.</p>","PeriodicalId":18405,"journal":{"name":"Metabolic syndrome and related disorders","volume":" ","pages":"357-365"},"PeriodicalIF":1.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Associations of Sleep Quality with Life's Essential 8 Cardiovascular Health Score and Metabolic Syndrome Among US Adults.\",\"authors\":\"Zhi Lin, Nipith Charoenngam, Izzuddin M Aris\",\"doi\":\"10.1089/met.2025.0033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Background:</i></b> Recent studies have identified a U-shaped association between sleep duration and both poor cardiovascular health (CVH) and metabolic syndrome (MetS). However, the extent to which sleep quality affects cardiometabolic health remains understudied. Here, we examined associations of sleep quality with CVH and MetS. <b><i>Methods:</i></b> In a nationally representative cross-sectional study of US adults (<i>n</i> = 3,293), we assessed sleep quality using the Pittsburgh Sleep Quality Index (PSQI), operationalized as a continuous score (range 0-23 points) and binary (good vs. poor sleep quality) variable. We derived CVH score (range 0-100 points) using the Life's Essential 8 construct, and defined MetS using the National Cholesterol Education Program Adult Treatment Panel III criteria. We examined associations via regression models, adjusting for sociodemographic and lifestyle factors. <b><i>Results:</i></b> In fully adjusted models, a 1-point higher PSQI score was associated with lower CVH scores (β -0.61; 95% CI -0.72, -0.51) and higher odds of MetS (OR 1.02; 95% CI 1.00, 1.03). Similarly, poor (vs. good) quality sleep was associated with lower CVH scores (β -4.1; 95% CI -5.4, -2.8) and higher odds of MetS (OR 1.27; 95% CI 1.04, 1.56). The associations with CVH score and MetS appeared to be driven primarily by health behaviors metrics and hypertriglyceridemia, respectively. No significant interactions were seen with age or gender. <b><i>Conclusions:</i></b> In this cross-sectional study, individuals with poor sleep quality were found to have worse CVH scores and higher odds of MetS. Future studies could explore whether strategies promoting better quality sleep would help improve CVH and prevent MetS.</p>\",\"PeriodicalId\":18405,\"journal\":{\"name\":\"Metabolic syndrome and related disorders\",\"volume\":\" \",\"pages\":\"357-365\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Metabolic syndrome and related disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/met.2025.0033\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolic syndrome and related disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/met.2025.0033","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/19 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:最近的研究已经确定了睡眠时间与心血管健康不良(CVH)和代谢综合征(MetS)之间的u型关联。然而,睡眠质量对心脏代谢健康的影响程度仍未得到充分研究。在这里,我们研究了睡眠质量与CVH和MetS之间的关系。方法:在一项具有全国代表性的美国成年人横断面研究中(n = 3293),我们使用匹兹堡睡眠质量指数(PSQI)评估睡眠质量,该指数以连续得分(范围0-23分)和二元(睡眠质量好坏)变量进行操作。我们使用Life's Essential 8结构得出CVH评分(范围0-100分),并使用国家胆固醇教育计划成人治疗小组III标准定义MetS。我们通过回归模型,调整了社会人口统计学和生活方式因素来检验相关性。结果:在完全调整的模型中,PSQI评分高1分与CVH评分低相关(β -0.61;95% CI -0.72, -0.51)和更高的MetS几率(OR 1.02;95% ci 1.00, 1.03)。同样,睡眠质量差(与良好相比)与较低的CVH评分相关(β -4.1;95% CI -5.4, -2.8)和更高的MetS几率(OR 1.27;95% ci 1.04, 1.56)。CVH评分和MetS的相关性似乎主要分别由健康行为指标和高甘油三酯血症驱动。年龄和性别之间没有明显的相互作用。结论:在这项横断面研究中,睡眠质量差的个体CVH评分更差,met的几率更高。未来的研究可以探索促进高质量睡眠的策略是否有助于改善CVH和预防MetS。
Associations of Sleep Quality with Life's Essential 8 Cardiovascular Health Score and Metabolic Syndrome Among US Adults.
Background: Recent studies have identified a U-shaped association between sleep duration and both poor cardiovascular health (CVH) and metabolic syndrome (MetS). However, the extent to which sleep quality affects cardiometabolic health remains understudied. Here, we examined associations of sleep quality with CVH and MetS. Methods: In a nationally representative cross-sectional study of US adults (n = 3,293), we assessed sleep quality using the Pittsburgh Sleep Quality Index (PSQI), operationalized as a continuous score (range 0-23 points) and binary (good vs. poor sleep quality) variable. We derived CVH score (range 0-100 points) using the Life's Essential 8 construct, and defined MetS using the National Cholesterol Education Program Adult Treatment Panel III criteria. We examined associations via regression models, adjusting for sociodemographic and lifestyle factors. Results: In fully adjusted models, a 1-point higher PSQI score was associated with lower CVH scores (β -0.61; 95% CI -0.72, -0.51) and higher odds of MetS (OR 1.02; 95% CI 1.00, 1.03). Similarly, poor (vs. good) quality sleep was associated with lower CVH scores (β -4.1; 95% CI -5.4, -2.8) and higher odds of MetS (OR 1.27; 95% CI 1.04, 1.56). The associations with CVH score and MetS appeared to be driven primarily by health behaviors metrics and hypertriglyceridemia, respectively. No significant interactions were seen with age or gender. Conclusions: In this cross-sectional study, individuals with poor sleep quality were found to have worse CVH scores and higher odds of MetS. Future studies could explore whether strategies promoting better quality sleep would help improve CVH and prevent MetS.
期刊介绍:
Metabolic Syndrome and Related Disorders is the only peer-reviewed journal focusing solely on the pathophysiology, recognition, and treatment of this major health condition. The Journal meets the imperative for comprehensive research, data, and commentary on metabolic disorder as a suspected precursor to a wide range of diseases, including type 2 diabetes, cardiovascular disease, stroke, cancer, polycystic ovary syndrome, gout, and asthma.
Metabolic Syndrome and Related Disorders coverage includes:
-Insulin resistance-
Central obesity-
Glucose intolerance-
Dyslipidemia with elevated triglycerides-
Low HDL-cholesterol-
Microalbuminuria-
Predominance of small dense LDL-cholesterol particles-
Hypertension-
Endothelial dysfunction-
Oxidative stress-
Inflammation-
Related disorders of polycystic ovarian syndrome, fatty liver disease (NASH), and gout